CORC  > 复旦大学上海医学院
Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis
Wu, Yougen; Wang, Yang; Gu, Yuting; Xia, Ju; Kong, Xiaoyang; Qian, Qingqing; Hong, Yang
刊名HEMATOLOGY
2017
卷号22期号:10
关键词Anti-CD20 antibody hematological oncology adverse effects progression-free survival overall survival
ISSN号1024-5332
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3610671
专题复旦大学上海医学院
推荐引用方式
GB/T 7714
Wu, Yougen,Wang, Yang,Gu, Yuting,et al. Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis[J]. HEMATOLOGY,2017,22(10).
APA Wu, Yougen.,Wang, Yang.,Gu, Yuting.,Xia, Ju.,Kong, Xiaoyang.,...&Hong, Yang.(2017).Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis.HEMATOLOGY,22(10).
MLA Wu, Yougen,et al."Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis".HEMATOLOGY 22.10(2017).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace